固体瘤中的美索林:生物学,生物标志物的实用性和治疗向
Ilary Ruscito1,2, Elizaveta Baisheva1,3, Eliane T Taube4
1Tumor Bank Ovarian Cancer Network, Berlin, Germany.
Current opinion in obstetrics & gynecology
|December 10, 2025
概括
梅索他林 (MSLN) 是一种可向蛋白质,用于各种癌症. 在治疗早期针对MSLN,特别是在卵巢癌中,可能会改善患者的生存结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 梅索他林 (MSLN) 是一种表面糖蛋白,参与细胞粘附和转移.
- 在中皮瘤,高度血清性卵巢癌 (HGSOC),胰腺癌和胆管癌中观察到MSLN表达.
- 它的瘤受限表达使MSLN成为一个有吸引力的治疗点.
研究的目的:
- 审查MSLN在癌症传播中的作用.
- 评估目前正在临床试验中的MSLN向疗法.
- 分析MSLN表达模式及其与实体瘤临床结果的相关性.
主要方法:
- 审查关于MSLN生物学和治疗的现有文献.
- 在各种固体瘤中分析MSLN表达数据.
- MSLN表达与临床参数的相关性,如FIGO阶段,白金敏感性和存活率.
主要成果:
- 在各种固体瘤组织学中表达MSLN.
- MSLN表达与FIGO阶段和敏感度相关.
- 在原发性卵巢癌中MSLN表达较高与HGSOC患者的更好的生存率有关.
结论:
- MSLN是固体瘤的相关目标.
- 针对MSLN的向疗法显示出希望,但面临诸如抗原分泌等挑战.
- 针对MSLN的早期治疗策略可能比在复发情况下使用的更有效.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


